featured
Nimotuzumab Plus Gemcitabine for KRAS Wild-Type Locally Advanced or Metastatic Pancreatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer
J. Clin. Oncol 2023 Aug 30;[EPub Ahead of Print], S Qin, J Li, Y Bai, Z Wang, Z Chen, R Xu, J Xu, H Zhang, J Chen, Y Yuan, T Liu, L Yang, H Zhong, D Chen, L Shen, C Hao, D Fu, Y Cheng, J Yang, Q Wang, B Qin, H Pan, J Zhang, X Bai, Q ZhengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.